Analyst consensus rating

Sanofi Analyst Rating: Buy

Direct answer

Sanofi's consensus rating is Buy.

9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $54.92.
Forecast evidence checked November 21, 2026.

Get free Sanofi email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$46.52
Average price target
$54.92
High price target
$63.00
Low price target
$45.00
Low target gap
-3.3%
Target upside
+18.1%
High target gap
+35.4%
Target range width
38.7%
Consensus rating
Buy
Analysts
9
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Sanofi?

Sanofi has a verified Buy consensus. The same dataset has an average price target of $54.92.

How far are Sanofi's low and high targets from the recorded price?

The low target implies -3.3%, while the high target implies +35.4%.

How many analysts are included in Sanofi's consensus?

The verified consensus includes 9 analysts.

How is Sanofi's target upside or downside calculated?

The average target of $54.92 is divided by the recorded price of $46.52, then one is subtracted to produce +18.1%. This does not guarantee a future return.

When was Sanofi's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.